Belando, Roselyn .

HRN: 27-37-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2025
CEFUROXIME 1.5GM (VIAL)
06/25/2025
06/26/2025
IV
1.5 G
Q8
Urinary Tract Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines